Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nancy Stagliano currently holds 255,635 shares of Pandion Therapeutics, Inc. (PAND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy Stagliano has been a net buyer of PAND stock. They have purchased $18.0K and sold $0 worth of shares.
Nancy Stagliano's most recent insider trade was on Sep 21, 2026, when they sold 255,635 shares at $0.00 per share.
Nancy Stagliano serves as Executive at Pandion Therapeutics, Inc. (PAND). They have executed 6 insider transactions totaling $18.0K over their tenure at the company.
Nancy Stagliano holds the position of Executive at Pandion Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Nancy Stagliano has shown a buying trading pattern, with $18.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Nancy Stagliano was on Apr 1, 2021, when they sold $4.4M worth of PAND shares. This transaction involved 73,067 shares at $60.00 per share.
Nancy Stagliano currently owns 255,635 shares of Pandion Therapeutics, Inc. (PAND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nancy Stagliano's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nancy Stagliano has 6 Form 4 filings on record as an insider at Pandion Therapeutics, Inc..
Set alerts for Nancy Stagliano and 40,000+ other insiders.